Feb 12, 2022

Despite what the commercial for the drug is promising Diabetes is not just controllable but it’s reversable and preventable. After all, no one wants to maintain the fire that’s burning down their house they want to put it out! And so, it is with this disease that’s destroying your body – you want to put it out! So, here’s some great news!

A new meta-analysis conducted in Italy has corroborated earlier research that the essential mineral magnesium dramatically reduces diabetes symptoms. The main outcome, according to researchers, was “a decline in insulin resistance with magnesium intake, especially in subjects with heightened risk of diabetes.”

The meta-analysis included 25 random, double-blind controlled trials, and the results were published in Nutrients in November 2021.

The need for supplementation

The research underpins earlier findings about the positive association between magnesium supplementation and people with or at a high risk of diabetes. In addition, the researchers also found that magnesium “performance” improved when insulin was present, and that magnesium intake was well-tolerated among all study subjects, with no significant adverse effects.

The health benefits of magnesium intake for people with diabetes is extensively documented; however, the proportion of people meeting the recommended daily allowance for magnesium remains low in the world’s populations. Scientists say supplementation in high-risk populations (such as diabetes sufferers, the elderly, and pregnant women) is often necessary.

Magnesium supplementation benefits don’t stop at diabetes: it has also been found to assuage the symptoms associated with metabolic diseases, gastrointestinal conditions and infectious diseases.

Study details

Researchers conducting the meta-analysis compared the parameters of glucose metabolism and insulin sensitivity between subjects who had been treated with oral magnesium supplements. The results were then compared to the placebo groups. The difference between mean magnesium and placebo groups was calculated using follow-up data, applying a random-effect model.

In the review conclusion, reviewers stated: “Magnesium may have an action in improving insulin secretion from pancreatic beta-cells…. whilst the main action of magnesium seems to be attributable to a decrease in insulin resistance, particularly in those at high risk of diabetes, indicating that it is likely that magnesium acts better when a deposit of insulin is present.”

Other notable observations on the effect of magnesium on glucose and insulin-sensitivity include a significant reduction in fasting plasma glucose. This was observed in 325 participants with diabetes and in 482 subjects at high risk of diabetes in 11 of the studies reviewed. Considerable improvements in oral glucose tolerance two hours after supplementation were also identified in three studies involving 210 subjects.

Study qualifiers

To qualify for the review studies had to involve random control trial protocol; follow a double-blind design; include participants with diabetes or at high-risk of developing diabetes; use oral magnesium supplementation; include an assessment of glucose metabolism or insulin sensitivity parameters; and adhere with sufficient quality standards.

Several conditions were considered as placing people at high risk of diabetes, including obesity/overweight, metabolic syndrome, renal failure, family history of diabetes, and prediabetes.

The vast majority of studies under review focused on subjects with type 2 diabetes. One study targeted pregnant women, while another targeted subjects with type 1 diabetes. Ten random controlled trials had a parallel design, while three used a crossover design.

The review was carried out by two independent investigators who identified relevant literature using several databases. Relevant data was extracted for analysis, and then a third investigator triple-checked the data.

Earlier research, conducted in Germany in 2011, came to similar conclusions. The study determined that daily supplements of magnesium for six months improved two out of three measures of insulin sensitivity compared with placebo. Meanwhile blood sugar levels, measured as fasting levels of glucose in the blood, improved by about 7 percent. The research was published in Diabetes, Obesity and Metabolism in March 2011.

The type and dosage of the magnesium needed must be specific for the individual which is something we determine for all our clients at Pro-Active Wellness whenever suggesting the use of supplements.

As good as magnesium is for all of us, its benefit has become even greater for those that are diabetic.

Sources include: Nutrients, Diabetes, Obesity and Metabolism.